MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,263 | +403.8% | 2,021,467 | +1205.0% | 0.01% | +250.0% |
| Q2 2023 | $509,618 | -44.5% | 154,899 | -30.7% | 0.00% | -85.7% |
| Q1 2023 | $918,125 | +1853.5% | 223,388 | +2076.4% | 0.01% | +1300.0% |
| Q2 2022 | $47,000 | -97.0% | 10,264 | -97.4% | 0.00% | -97.6% |
| Q1 2022 | $1,573,000 | -35.9% | 394,250 | -0.1% | 0.04% | -44.7% |
| Q4 2021 | $2,455,000 | +118.2% | 394,760 | +230.9% | 0.08% | +137.5% |
| Q3 2021 | $1,125,000 | +113.5% | 119,302 | +207.4% | 0.03% | +77.8% |
| Q2 2021 | $527,000 | +2191.3% | 38,815 | +172.3% | 0.02% | +1700.0% |
| Q3 2019 | $23,000 | -59.6% | 14,252 | +1.8% | 0.00% | -83.3% |
| Q2 2019 | $57,000 | – | 14,003 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |